Redeye: OssDsign - Catalyst sets up for a turnaround
Redeye raises its base case following a case review of OssDsign and we positively reconsider its commercial prospects for Catalyst. Once the cash position is sorted (we anticipate an equity issue in the coming months), we believe investors will begin recognizing the new equity story of OssDsign.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/